Literature DB >> 6604916

Enhancement of specific antitumor immunity in mice fed a diet enriched in vitamin A acetate.

M Malkovský, C Doré, R Hunt, L Palmer, P Chandler, P B Medawar.   

Abstract

Age-matched male CBA mice on a conventional or a vitamin A acetate (VAOAc)-rich diet were immunized with irradiated cloned 3-methylcholanthrene- or Harvey sarcoma virus-induced (McSa-1 or HT3-2.1) sarcoma cells and then challenged with viable corresponding or unrelated (non-crossreacting) syngeneic sarcoma cells. The survival of the specifically immunized mice on the VAOAc diet was significantly prolonged in comparison with all control groups of mice as assessed by using logrank tests. Moreover, the specific immunization markedly decreased the incidence of tumors after the McSa-1 (but not HT3-2.1) challenge in a group of mice on the VAOAc diet (5% tumor incidence) compared with the equivalent group on the control diet (50% tumor incidence). Neither the VAOAc diet nor in vivo immunization alone or combined influenced natural killer cell activity. Specific T-cell-mediated cytotoxicity after in vivo priming and in vitro boosting with sarcoma cells was increased in VAOAc-fed mice. However, the marginal increase in cytotoxicity does not in itself explain the strikingly increased resistance to tumor transplants in preimmunized mice on the VAOAc diet in comparison with preimmunized mice on the control diet. The results indicate that a diet enriched in VAOAc can modify the ability of the immune system of a mouse to respond effectively to tumor antigens and can influence whether a tumor grows or regresses.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6604916      PMCID: PMC394289          DOI: 10.1073/pnas.80.20.6322

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  A transplantable mast-cell neoplasm in the mouse.

Authors:  T B DUNN; M POTTER
Journal:  J Natl Cancer Inst       Date:  1957-04       Impact factor: 13.506

2.  Augmentation of specific tumor immunity against a syngeneic SV40-induced sarcoma in mice by retinoic acid.

Authors:  M Glaser; R Lotan
Journal:  Cell Immunol       Date:  1979-06       Impact factor: 4.868

3.  Micromethods for induction and assay of mouse mixed lymphocyte reactions and cytotoxicity.

Authors:  E Simpson; R Gordon; M Taylor; J Mertin; P Chandler
Journal:  Eur J Immunol       Date:  1976-07       Impact factor: 5.532

4.  Antitumor action of vitamin A in mice inoculated with adenocarcinoma cells.

Authors:  G Rettura; A Schittek; M Hardy; S M Levenson; A Demetriou; E Seifter
Journal:  J Natl Cancer Inst       Date:  1975-06       Impact factor: 13.506

5.  Tumor suppression by Mycobacterium bovis (strain BCG) enhanced by vitamin A.

Authors:  M S Meltzer; B E Cohen
Journal:  J Natl Cancer Inst       Date:  1974-08       Impact factor: 13.506

6.  Vitamin A: adjuvant and steroid antagonist in the immune response.

Authors:  B E Cohen; I K Cohen
Journal:  J Immunol       Date:  1973-11       Impact factor: 5.422

7.  Nonspecific inhibitor released by T acceptor cells reduces the production of interleukin-2.

Authors:  M Malkovsky; G L Asherson; B Stockinger; M C Watkins
Journal:  Nature       Date:  1982-12-16       Impact factor: 49.962

8.  Retinoic acid suppression of human leukocyte interferon production.

Authors:  J Abb; H Abb; F Deinhardt
Journal:  Immunopharmacology       Date:  1982-08

9.  Nonspecific inhibitor of DNA synthesis elaborated by T acceptor cells. I. Specific hapten- and I-J-driven liberation of an inhibitor of cell proliferation by Lyt-1-2+ cyclophosphamide-sensitive T acceptor cells armed with a product of Lyt-1+2+-specific suppressor cells.

Authors:  M Malkovský; G L Asherson; P Chandler; V Colizzi; M C Watkins; M Zembala
Journal:  J Immunol       Date:  1983-02       Impact factor: 5.422

10.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1977-01       Impact factor: 7.640

View more
  14 in total

1.  Micronutrient deficiencies in children--the problem and extent.

Authors:  P Bhaskaram
Journal:  Indian J Pediatr       Date:  1995 Mar-Apr       Impact factor: 1.967

Review 2.  Schiff base forming drugs: mechanisms of immune potentiation and therapeutic potential.

Authors:  H Chen; J Rhodes
Journal:  J Mol Med (Berl)       Date:  1996-09       Impact factor: 4.599

Review 3.  Leukocyte homing, fate, and function are controlled by retinoic acid.

Authors:  Yanxia Guo; Chrysothemis Brown; Carla Ortiz; Randolph J Noelle
Journal:  Physiol Rev       Date:  2015-01       Impact factor: 37.312

4.  Effects of orally administered retinol on natural killer cell activity in wild type BALB/c and congenitally athymic BALB/c mice.

Authors:  L D Fraker; S A Halter; J T Forbes
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

5.  Influence of dendritic cells on tumor growth.

Authors:  S C Knight; R Hunt; C Dore; P B Medawar
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

6.  Retinoic acid protects Langerhans' cells from the effects of the tumour promotor 12-O-tetradecanoylphorbol 13-acetate.

Authors:  G M Halliday; J L Dickinson; H K Muller
Journal:  Immunology       Date:  1989-07       Impact factor: 7.397

7.  Generation of lymphokine-activated killer cells does not require DNA synthesis.

Authors:  M Malkovský; M Jíra; J Madar; V Malkovska; B Loveland; G L Asherson
Journal:  Immunology       Date:  1987-03       Impact factor: 7.397

8.  Lymphokine-activated killer cell activity in rheumatoid arthritis.

Authors:  M Jíra; M Malkovský; A M Denman; B Loveland; D Lyons; A G Dalgleish; A D Webster
Journal:  Clin Exp Immunol       Date:  1987-06       Impact factor: 4.330

9.  Acquired immunological tolerance of foreign cells is impaired by recombinant interleukin 2 or vitamin A acetate.

Authors:  M Malkovský; P B Medawar; D R Thatcher; J Toy; R Hunt; L S Rayfield; C Doré
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

10.  Augmentation of interleukin-2 production and delayed hypersensitivity in mice infected with Mycobacterium bovis and fed a diet supplemented with vitamin A acetate.

Authors:  V Colizzi; M Malkovsky
Journal:  Infect Immun       Date:  1985-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.